These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14486711)
21. ORAL CONTRACEPTION IN PRACTICE. JACKSON MC J Reprod Fertil; 1963 Aug; 6():153-73. PubMed ID: 14065347 [No Abstract] [Full Text] [Related]
22. [CONSIDERATIONS ON THE PHARMACOLOGY AND THE MECHANISM OF ACTION OF SUBSTANCES WHICH INHIBIT OVULATION]. TAUSK M Acta Ginecol (Madr); 1965 Jun; 16():363-75. PubMed ID: 14341897 [No Abstract] [Full Text] [Related]
24. [CORPUS LUTEUM FORMATION DURING THE TAKING OF HORMONAL CONTRACEPTIVES]. ERB H; LUDWIG KS Gynaecologia; 1965; 159():309-15. PubMed ID: 14336506 [No Abstract] [Full Text] [Related]
25. [APROPOS OF THE OVULATION-INHIBITING DOSAGE OF ORAL GESTAGENS]. SZONTAGH FE; SAS M Zentralbl Gynakol; 1964 Mar; 86():410-2. PubMed ID: 14198198 [No Abstract] [Full Text] [Related]
26. [RESULTS IN THE USE OF ORAL OVULATION INHIBITORS (ORAL CONTRACEPTIVES)]. SWAAB LI Ned Tijdschr Geneeskd; 1964 May; 108():1070-6. PubMed ID: 14156330 [No Abstract] [Full Text] [Related]
27. Contraception after unprotected sex. Blaney CL Netw Res Triangle Park N C; 1994 Dec; 15(2):4-8. PubMed ID: 12319047 [TBL] [Abstract][Full Text] [Related]
28. New progesteronic hormones in the control of fertility. RUBIN A Pa Med J; 1962 May; 65():581-3. PubMed ID: 14494892 [No Abstract] [Full Text] [Related]
29. ORAL CONTRACEPTION. PHARMACOLOGICAL AND BIOCHEMICAL ASPECTS. FRANCIS HH Proc R Soc Med; 1964 Mar; 57(3):203-4. PubMed ID: 14130872 [No Abstract] [Full Text] [Related]
30. Antiovulatory drugs and indications for their use. GREENBLATT RB Med Clin North Am; 1961 Jul; 45():973-88. PubMed ID: 13708280 [No Abstract] [Full Text] [Related]
31. [CASE OF ANASARCA DURING ORAL CONTRACEPTION]. BENTZEN AJ Ugeskr Laeger; 1964 Jan; 126():112-5. PubMed ID: 14142321 [No Abstract] [Full Text] [Related]
32. ORAL CONTRACEPTION. BRYANS FE Can Med Assoc J; 1965 Feb; 92(6):287-8. PubMed ID: 14270213 [No Abstract] [Full Text] [Related]
33. MESTRANOL IN OVULATION SUPPRESSION. YEN SS Fertil Steril; 1965; 16():97-100. PubMed ID: 14256105 [No Abstract] [Full Text] [Related]
34. Effectiveness of an oral contraceptive; effects of a progestin-estrogen combination upon fertility, menstrual phenomena, and health. PINCUS G; GARCIA CR; ROCK J; PANIAGUA M; PENDLETON A; LARAQUE F; NICOLAS R; BORNO R; PEAN V Science; 1959 Jul; 130(3367):81-3. PubMed ID: 13668539 [No Abstract] [Full Text] [Related]
35. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors. Fraser IS; Jansen RP Contraception; 1983 Jun; 27(6):531-51. PubMed ID: 6413129 [TBL] [Abstract][Full Text] [Related]
36. TRIAL OF A NEW FORM OF ORAL CONTRACEPTIVE. CARRUTHERS GB Br J Clin Pract; 1965 Aug; 19():455-60. PubMed ID: 14324833 [No Abstract] [Full Text] [Related]
37. Principles of oral contraception. 1. Mode of action of oral contraceptives. Carey HM Med J Aust; 1971 Dec; 2(23):1184-6. PubMed ID: 5134707 [No Abstract] [Full Text] [Related]
38. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities. Zaki K; Kamal I; Talaat MM; Rashad S; Nour H Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027 [TBL] [Abstract][Full Text] [Related]
39. [Advantages and risks of hormonal contraception]. Mall-Haefeli M Fortschr Med; 1982 Apr; 100(16):723-8. PubMed ID: 7084860 [TBL] [Abstract][Full Text] [Related]